Understand PB we have a wild ride ahead of us.:-) Since BioAdaptives, Inc.(BDPT) announced its intention to spin off its Livestock Impact Division as a wholly-owned subsidiary on April 20, 2023.
Are you capable of telling the truth? This is a marketing company with hardly any employees. They say it directly in their own public filings. The spinoff of LiveStock was a very simple move to separate the animal business from the human business. There was nothing to do. There is no magic corporate hocus pocus going on behind the scenes while BDPT registers new shares of LiveStock. All they did was create a wholly-owned subsidiary with the newly identified management team. LiveStock is still under the BioAdaptives umbrella. This is such basic stuff.
"Employees: The Company currently has 3 executive employees and 3 part-time employees. We retain hourly labor on an as-needed basis and professional consultants to operate our business. The management of the Company expects to continue to use outside consultants, attorneys, and accountants, as necessary, as long as it is seeking and evaluating business opportunities. The need for additional employees, and their availability, will be addressed in connection with the decision whether or not to acquire or participate in specific business opportunities."
You act like this is some huge conglomerate when clearly it is not. All of this information is in the public filings.
Here is a quote about what actually happened with LiveStock:
"Our [one needs to understand the basic concept that "our" refers to BioAdaptive's ownership/licensing] animal products include an Equine All-in-One™ and Equine All-In-One Plus™ formulation, which we ["we" meaning our wholly-owned subsidiary called LiveStock] market to trainers, horse owners and boarding stables, and a Canine All-in-One™ that we [get it yet?] market directly to consumers. Anecdotal and testimonial reports are that the equine products provide significant relief from exercise induced pulmonary hemorrhaging, as well as improved coat and mane appearance and hoof health. The canine products have demonstrated significant rejuvenating benefits for older dogs, improving overall appearance and energy levels. Effective April 2023, FBRTherapy Division has been appointed its exclusive Distributor for all LiveStock Impact’s products, as such The Company also negotiated with the supplier for the exclusive marketing rights to these products from the non-exclusive license it has held since June 2022."
The LiveStock products are clearly identified as the horse and dog products. FBRTherapy Division now sells the products on behalf of LiveStock, with the money being allocated and reported on the BioAdaptives quarterly report. So, let's get something straight. There is no crazy complicated business divestment or synergy psychobabble BS going on. LiveStock isn't even doing anything to sell the horse and dog products anymore. They licensed out the sales efforts to FBRTherapy. And when sales are actually made, guess what??? BDPT reports the revenues on its quarterly report:
"Since the appointment of FCBTherapy as its exclusive Distributor, LiveStock impact is withdrawing from its own websale and is encouraged with the first initial wholesale order from FCBTherapy is over $9000 which is double the last 6 months gross sales."
So, to recap, LiveStock doesn't do anything anymore except collect money from sales made by FCBTherapy. And that money is then reported as an asset on the BDPT balance sheet. THERE WILL BE NO MAGICAL IPO SPINOFF SHARES!!!!!!!!!!!!
Just read what the company itself actually says about it's equine business:
"With regard to animal products, the Company’s Livestock Impact Division under the direction its President, Bruce Colclasure, a National Cutting Horse Association champion, who owns and operates the Flying C Bar Ranch in Oklahoma and a breeder and trainer of over 80 NCHA champion cutting horses, continues to explore new opportunities in this emerging market. Mr. Colclasure uses and endorses our Equine All-in-One™ and derivative booster products providing valuable feedback and testimonials regarding their benefits. In addition, a high-performance special formulation of our All-in-One product continues to be marketed with exceptional results. We expect to expand the outreach in 2023.
In light of the failures of our past social media campaigns, we recommenced a social media effort this quarter with better response. The Company continues its marketing affiliate outreach program for the equine products, directly contacting the principals of horse clubs and associations, offering discounts, samples and other inducements, seeking to develop “product champion” and “maven” relationships. We contacted principals in organizations with thousands of members and many more thousands of horses. Since the 4th Quarter 2022, we have been distributing samples and marketing materials to over 40 principals and influencers in regional and breed-specific equine associations and in anticipation of receiving feedback from these marketing initiatives in 2023."
It is plain English. The guy who now runs LiveStock is a ranch owner, breeder and trainer in Oklahoma. He uses the products for his horses. He thinks they are great. The big upcoming plan is to give discounts, free samples, heck beg other breeders and trainers to use the supplements on their horses to get anecdotal feedback so they can hopefully actually sell some snake-oil. Goodness, it does not get any more clear from the horse's mouth (sorry, couldn't resist!)
You can pump nonsense all you want but anyone can read exactly what the company says about itself:
"Because our business plan relies on marketing products we license from others, our capital requirements are generally limited to general operations and administration, including the costs of continuing as a public company, and our variable costs scale up or down based on our actual sales. We believe that increasing our marketing expenses will be critical to establishing sales sufficient to cover our expenses and, if possible, generate a profit. We anticipate using our existing financing operations to do so, which will almost certainly require either the issuance of equity or increases in existing levels of debt or, most likely, both.
Management’s plans include the raising of capital through the equity markets to fund future operations, seeking additional acquisitions, and generating revenue through our business. However, even if we do raise sufficient capital to support our operating expenses and generate adequate revenues, there can be no assurances that the revenue will be sufficient to enable us to develop business to a level where we will generate profits and positive cash flows from operations. These matters raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty."
Bet you wish you would have sold at .005, yes?????